{"id":"https://openalex.org/W4281695136","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e21522","title":"Association of immune-related adverse events with immune-checkpoint inhibitors and treatment response in melanoma patients.","display_name":"Association of immune-related adverse events with immune-checkpoint inhibitors and treatment response in melanoma patients.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4281695136","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e21522"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.e21522","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e21522","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.e21522","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041022686","display_name":"Benigno Rodriguez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benigno Rodriguez","raw_affiliation_strings":["The American British Cowdray Medical Center, Mexico City, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The American British Cowdray Medical Center, Mexico City, Mexico;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072040779","display_name":"Jos\u00e9 Fabi\u00e1n Mart\u00ednez\u2010Herrera","orcid":"https://orcid.org/0000-0001-9894-2204","observed_orcids":["https://orcid.org/0000-0001-9894-2204"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Fabi\u00e1n Mart\u00ednez-Herrera","raw_affiliation_strings":["The American British Cowdray Medical Center, Ciudad De M\u00e9xico, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The American British Cowdray Medical Center, Ciudad De M\u00e9xico, Mexico;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064657315","display_name":"Lorena L\u00f3pez Zepeda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lorena L\u00f3pez Zepeda","raw_affiliation_strings":["The American British Cowdray Medical Center, Mexico City, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The American British Cowdray Medical Center, Mexico City, Mexico;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047358338","display_name":"Guillermo Olivares","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guillermo Olivares","raw_affiliation_strings":["The American British Cowdray Medical Center, Mexico City, DF, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The American British Cowdray Medical Center, Mexico City, DF, Mexico;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041944119","display_name":"Alberto Villalobos","orcid":"https://orcid.org/0000-0001-7640-734X","observed_orcids":["https://orcid.org/0000-0001-7640-734X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alberto Villalobos","raw_affiliation_strings":["The American British Cowdray Medical Center, Mexico City, DF, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The American British Cowdray Medical Center, Mexico City, DF, Mexico;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Fernando Perez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134034","display_name":"Centro M\u00e9dico ABC","ror":"https://ror.org/03e36d037","country_code":"MX","type":"healthcare","lineage":["https://openalex.org/I4210134034"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Fernando Perez","raw_affiliation_strings":["Centro Medico ABC y Hospital Angeles Lomas, Mexico, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro Medico ABC y Hospital Angeles Lomas, Mexico, Mexico;","institution_ids":["https://openalex.org/I4210134034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078595508","display_name":"Christian Patricio Camacho Limas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christian Patricio Camacho Limas","raw_affiliation_strings":["American British Cowdray Medical Center, Mexico City, DF, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"American British Cowdray Medical Center, Mexico City, DF, Mexico;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022513587","display_name":"Juan Alberto Serrano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan Alberto Serrano","raw_affiliation_strings":["The American British Cowdray Medical Center, Mexico City, DF, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The American British Cowdray Medical Center, Mexico City, DF, Mexico;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025290231","display_name":"Omar Serrano Villamayor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134034","display_name":"Centro M\u00e9dico ABC","ror":"https://ror.org/03e36d037","country_code":"MX","type":"healthcare","lineage":["https://openalex.org/I4210134034"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Omar Serrano Villamayor","raw_affiliation_strings":["Centro M\u00e9dico ABC, Mexico City, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro M\u00e9dico ABC, Mexico City, Mexico;","institution_ids":["https://openalex.org/I4210134034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110776428","display_name":"Ervin Sa\u00fal Enciso L\u00f3pez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ervin Sa\u00fal Enciso L\u00f3pez","raw_affiliation_strings":["The American British Cowdray Medical Center, Mexico City, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The American British Cowdray Medical Center, Mexico City, Mexico;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067293845","display_name":"Daniela Shveid Gerson","orcid":"https://orcid.org/0000-0002-9501-3060","observed_orcids":["https://orcid.org/0000-0002-9501-3060"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniela Shveid Gerson","raw_affiliation_strings":["The American British Cowdray Medical Center, Mexico City, DF, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The American British Cowdray Medical Center, Mexico City, DF, Mexico;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024005250","display_name":"Efrain Isaias Camarin Sanchez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Efrain Isaias Camarin Sanchez","raw_affiliation_strings":["The American British Cowdray Medical Center, Mexico City, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The American British Cowdray Medical Center, Mexico City, Mexico;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022636371","display_name":"Diana Bonilla Molina","orcid":"https://orcid.org/0000-0002-0435-3247","observed_orcids":["https://orcid.org/0000-0002-0435-3247"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diana Bonilla Molina","raw_affiliation_strings":["The American British Cowdray Medical Center, Mexico, DF, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The American British Cowdray Medical Center, Mexico, DF, Mexico;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021288583","display_name":"Juan Manuel Tovar Cabrera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan Manuel Tovar Cabrera","raw_affiliation_strings":["American British Cowdray Medical Center, Mexico City, DF, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"American British Cowdray Medical Center, Mexico City, DF, Mexico;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078124643","display_name":"Cecilia Nehmad","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cecilia Nehmad","raw_affiliation_strings":["American British Cowdray Medical Center, Ciudad De M\u00e9xico, DF, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"American British Cowdray Medical Center, Ciudad De M\u00e9xico, DF, Mexico;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021003010","display_name":"Juan Jos\u00e9 Ju\u00e1rez\u2010Vignon Whaley","orcid":"https://orcid.org/0000-0001-5570-2147","observed_orcids":["https://orcid.org/0000-0001-5570-2147"]},"institutions":[{"id":"https://openalex.org/I4210102695","display_name":"Instituto Nacional de Enfermedades Respiratorias","ror":"https://ror.org/017fh2655","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210095685","https://openalex.org/I4210102695"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Juan Jose Juarez - Vignon Whaley","raw_affiliation_strings":["Instituto Nacional de Enfermedades Respiratorias, State of Mexico, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional de Enfermedades Respiratorias, State of Mexico, Mexico;","institution_ids":["https://openalex.org/I4210102695"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004226767","display_name":"Raquel Gerson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raquel Gerson","raw_affiliation_strings":["The American British Cowdray Medical Center, Mexico City, DF, Mexico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The American British Cowdray Medical Center, Mexico City, DF, Mexico;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"e21522","last_page":"e21522"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9829999804496765},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9139999747276306},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9700000286102295},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.7540000081062317},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9919999837875366},{"id":"https://openalex.org/keywords/vitiligo","display_name":"vitiligo","score":0.7319999933242798},{"id":"https://openalex.org/keywords/hypothyroidism","display_name":"hypothyroidism","score":0.9819999933242798},{"id":"https://openalex.org/keywords/pneumonitis","display_name":"pneumonitis","score":0.9660000205039978},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6850000023841858},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9399999976158142},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7329999804496765},{"id":"https://openalex.org/keywords/skin-toxicity","display_name":"skin toxicity","score":0.6290000081062317},{"id":"https://openalex.org/keywords/braf-v600e-mutation","display_name":"BRAF V600E mutation","score":0.8299999833106995},{"id":"https://openalex.org/keywords/advanced-melanoma","display_name":"advanced melanoma","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.946968674659729},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.9296311140060425},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.9219338893890381},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8342158794403076},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.769422173500061},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7360201478004456},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6822938919067383},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46297308802604675},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.44608137011528015},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4359017610549927},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.42635053396224976},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.323292076587677},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3222368359565735},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.23623409867286682},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.209316223859787},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1715615689754486},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.16099172830581665},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0630057156085968}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.e21522","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e21522","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.e21522","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4399965249","https://openalex.org/W4379341715","https://openalex.org/W4295564775","https://openalex.org/W4416075629","https://openalex.org/W4389068359","https://openalex.org/W3204288709","https://openalex.org/W3172914666","https://openalex.org/W3093924411","https://openalex.org/W4387015050","https://openalex.org/W4413771656"],"abstract_inverted_index":{"e21522":[0],"Background:":[1],"Immune-related":[2],"adverse":[3,73],"effects":[4],"(irAE\u00b4s)":[5],"of":[6,42,91,97,137,180,185,199,203,212,235,239,271,303,307,311,336,374],"immune-checkpoint":[7],"inhibitors":[8],"(ICIs)":[9],"have":[10,298,363],"been":[11],"linked":[12],"with":[13,58,63,78,85,99,103,237,273,340,345],"a":[14,50,140,299,364],"better":[15,267],"treatment":[16,62,196,377],"response":[17],"in":[18,81,178,197,233,268,331],"melanoma":[19,59,82,101],"patients,":[20],"especially":[21],"cutaneous":[22],"toxicities.":[23],"However,":[24],"little":[25],"is":[26,32,314,338],"known":[27],"regarding":[28],"other":[29],"irAE\u00b4s":[30,279],"which":[31],"important":[33,316],"as":[34,39,114,324,371],"they":[35],"can":[36,368],"be":[37,286,353,369],"used":[38,370],"clinical":[40,372],"markers":[41,373],"an":[43,278,375],"adequate":[44,376],"therapeutical":[45],"response.":[46],"Methods:":[47],"We":[48],"conducted":[49],"retrospective":[51],"study":[52],"on":[53],"patients":[54,83,98,138,213,236,272,346],"who":[55,276],"were":[56,113,117,132,151,206,231],"diagnosed":[57],"and":[60,75,130,154,170,183,223,244,255,263,292,305,357],"received":[61,214],"ICI\u00b4s":[64,190],"between":[65,105],"January":[66],"2015":[67],"until":[68],"December":[69],"2021,":[70,110],"immune":[71],"related":[72],"events":[74],"their":[76],"relationship":[77],"overall":[79],"survival":[80],"treated":[84,102],"ICIs":[86,104,344],"was":[87,123,159,176,191,265,327],"the":[88,160,181,192,227,269],"main":[89],"objective":[90],"this":[92,332],"study.":[93],"Results:":[94],"53":[95],"records":[96],"advance":[100],"january":[106],"2016":[107],"to":[108,285,297,343,352,362],"december":[109],"demographic":[111],"characteristics":[112],"follow:":[115],"64.2%":[116],"male,":[118],"mean":[119],"age":[120],"at":[121,260,289],"diagnoses":[122],"60.3":[124],"years,":[125],"41.5%":[126],"had":[127,139],"smoking":[128],"history":[129],"15.1%":[131],"Jewish.":[133],"At":[134],"diagnosis":[135],"73.6%":[136],"good":[141],"functional":[142],"status":[143],"(ECOG":[144],"0-1).":[145],"The":[146,248,309],"most":[147,161,249],"common":[148,162,250],"histological":[149],"subtypes":[150],"epithelioid":[152],"(34%),":[153],"nodular":[155],"(22.6%).":[156],"Lung":[157],"metastases":[158],"affected":[163],"site":[164],"(49.1%),":[165],"followed":[166],"by":[167],"brain":[168],"43.4%":[169],"non-regional":[171],"nodes":[172],"42.5%.":[173],"BRAF":[174],"mutations":[175],"determined":[177],"81.1%":[179],"biopsies":[182],"36%":[184],"them":[186,240],"being":[187,241,347],"V600E":[188],"mutation.":[189],"preferred":[193],"first":[194],"line":[195],"83%":[198],"cases,":[200],"median":[201,325],"number":[202],"administered":[204],"cycles":[205],"6":[207],"(range":[208],"1-54":[209],"cycles),":[210],"60.4%":[211],"pembrolizumab,":[215],"37.7%":[216],"nivolumab":[217,221],"plus":[218],"ipilimumab,":[219],"20.8%":[220],"monotherapy":[222],"5.7%":[224],"ipilimumab.":[225],"Throughout":[226],"studied":[228],"period":[229],"IrAE\u00b4s":[230],"reported":[232],"34%":[234],"66.7%":[238],"grade":[242,246],"1-2":[243],"33.3%":[245],"3-4.":[247],"IrAE\u2019s:":[251],"vitiligo":[252],"38.8%,":[253],"hypothyroidism22%":[254],"3.8%":[256],"pneumonitis.":[257],"Median":[258],"PFS":[259,318,326],"12":[261,290],"months":[262,291],"OS":[264,301],"significantly":[266,315],"group":[270],"irAE\u00b4s:":[274],"Patients":[275],"develop":[277],"are":[280],"7":[281,348],"times":[282,294,349,359],"more":[283,295,350,360],"likely":[284,296,351,361],"disease":[287,355],"free":[288,356],"4.1":[293,358],"longer":[300,365],"regardless":[302],"severity":[304],"type":[306],"toxicity.":[308],"impact":[310],"developing":[312],"irAEs":[313,337,367],"for":[317],"(HR:":[319],"11.9,":[320],"CI":[321],"95%:":[322],"3.28-4.71)":[323],"not":[328],"yet":[329],"reached":[330],"group.":[333],"Conclusions:":[334],"Development":[335],"associated":[339],"favorable":[341],"outcomes":[342],"12-month":[354],"OS.":[366],"response.[Table:":[378],"see":[379],"text]":[380]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2022-06-13T00:00:00"}